Literature DB >> 32400205

Epidemiology and Risk Factors of Osteosarcoma.

Leissan R Sadykova1, Atara I Ntekim2, Musalwa Muyangwa-Semenova3, Catrin S Rutland4, Jennie N Jeyapalan4, Nataliya Blatt4, Albert A Rizvanov5.   

Abstract

Osteosarcoma is a rare tumor diagnosed at any age; however younger age is a common risk factor. In addition, multiple factors are believed to contribute to higher rates of osteosarcoma, particularly race and gender. Although diagnosed worldwide, osteosarcoma is found to be more prevalent in Africa with high numbers of cases reported in Nigeria, Uganda, and Sudan. Additionally, higher rates are detected in African Americans, suggesting a genetic predisposition linked to race. This review focuses on identifying high risk factors of osteosarcoma with an emphasis on sarcoma epidemiology and risk factors in African countries.

Entities:  

Keywords:  Bone tumor; epidemiology; genetic markers; mesenchymal stem cell; pathogenesis

Year:  2020        PMID: 32400205     DOI: 10.1080/07357907.2020.1768401

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  37 in total

Review 1.  Emerging role of m6A modification in osteogenesis of stem cells.

Authors:  Zi Zou; Tiantian He; Ying Liu; Leliang Zheng; Yancheng Zhong; Yuqing Mo; Shuping Peng; Cijun Shuai
Journal:  J Bone Miner Metab       Date:  2022-01-29       Impact factor: 2.626

2.  Lentivirus-induced knockdown of IARS2 expression inhibits the proliferation and promotes the apoptosis of human osteosarcoma cells.

Authors:  Qi Liu; Feng Lin
Journal:  Oncol Lett       Date:  2022-06-15       Impact factor: 3.111

3.  LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway.

Authors:  Weitao Yao; Jingyu Hou; Guoqing Liu; Fangxing Wu; Qiang Yan; Liangyu Guo; Chuchu Wang
Journal:  Mol Ther Oncolytics       Date:  2022-03-08       Impact factor: 6.311

4.  Highly enriched exosomal lncRNA OIP5-AS1 regulates osteosarcoma tumor angiogenesis and autophagy through miR-153 and ATG5.

Authors:  Yumei Li; Shengming Lin; Xiaoliang Xie; Haixia Zhu; Tianyou Fan; Song Wang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

5.  Effect assessment of methotrexate in combination with other chemotherapeutic agents for osteosarcoma in children: A protocol for systematic review and meta-analysis.

Authors:  Jun-Ping Yan; Rong-Mei Xiang
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 6.  Role of MicroRNAs in Human Osteosarcoma: Future Perspectives.

Authors:  Lola Llobat; Olivia Gourbault
Journal:  Biomedicines       Date:  2021-04-23

7.  N6-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m6A/FOXM1 axis.

Authors:  Zhipeng Ren; Yongcheng Hu; Jie Sun; Yuxiang Kang; Guishi Li; Hejun Zhao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

8.  Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression.

Authors:  Jiayi Chen; Chenhong Qian; Peng Ren; Han Yu; Xiangjia Kong; Chenglong Huang; Huanhuan Luo; Gang Chen
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

9.  MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein.

Authors:  Lu Ding; Rongxin Sun; Qi Yan; Chengwei Wang; Xiaoping Han; Yong Cui; Rong Li; Jiwen Liu
Journal:  Aging (Albany NY)       Date:  2021-02-17       Impact factor: 5.682

Review 10.  The Role of lncRNA PCAT6 in Cancers.

Authors:  Siying Wang; Zhenyao Chen; Jingyao Gu; Xin Chen; Zhaoxia Wang
Journal:  Front Oncol       Date:  2021-07-13       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.